All download files including the archive files are now in a publicly accessible Google Storage Bucket. Downloads page links have been updated.

Not found

Our G-nome assistant hasn't been able to find this symbol report. Please check the URL or use our search to find what you are looking for.

Symbol report for RIGI

Stable symbol

HGNC data for RIGI

Approved symbol
RIGI
Approved name

RNA sensor RIG-I

Locus type
gene with protein product
HGNC ID
HGNC:19102
Symbol status
Approved
Previous symbols
DDX58
Previous names
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
DExD/H-box helicase 58
Alias symbols
RIG-I
FLJ13599
DKFZp434J1111
RIG-1
RIG1
Alias names
RNA helicase RIG-I
retinoic acid inducible gene I
Antiviral innate immune response receptor RIG-I
Chromosomal location
9p21.1
Bos taurus
RIGI VGNC:27979 VGNC
Canis familiaris
RIGI VGNC:39867 VGNC
Equus caballus
RIGI VGNC:17106 VGNC
Felis catus
RIGI VGNC:61418 VGNC
Macaca mulatta
RIGI VGNC:71672 VGNC
Mus musculus
Rigi MGI:2442858 Curated
Pan troglodytes
RIGI VGNC:8814 VGNC
Rattus norvegicus
Sus scrofa
RIGI VGNC:95905 VGNC
IUPHAR/BPS Guide to PHARMACOLOGY
The molecular mechanism of RIG-I activation and signaling.
Thoresen D et al. Immunol Rev 2021 Nov;304(1)154-168
Thoresen D, Wang W, Galls D, Guo R, Xu L, Pyle AM.
Immunol Rev 2021 Nov;304(1)154-168
Abstract: RIG-I is our first line of defense against RNA viruses, serving as a pattern recognition receptor that identifies molecular features common among dsRNA and ssRNA viral pathogens. RIG-I is maintained in an inactive conformation as it samples the cellular space for pathogenic RNAs. Upon encounter with the triphosphorylated terminus of blunt-ended viral RNA duplexes, the receptor changes conformation and releases a pair of signaling domains (CARDs) that are selectively modified and interact with an adapter protein (MAVS), thereby triggering a signaling cascade that stimulates transcription of interferons. Here, we describe the structural determinants for specific RIG-I activation by viral RNA, and we describe the strategies by which RIG-I remains inactivated in the presence of host RNAs. From the initial RNA triggering event to the final stages of interferon expression, we describe the experimental evidence underpinning our working knowledge of RIG-I signaling. We draw parallels with behavior of related proteins MDA5 and LGP2, describing evolutionary implications of their collective surveillance of the cell. We conclude by describing the cell biology and immunological investigations that will be needed to accurately describe the role of RIG-I in innate immunity and to provide the necessary foundation for pharmacological manipulation of this important receptor.
Retinoic acid-induced gene-I (RIG-I) associates with nucleotide-binding oligomerization domain-2 (NOD2) to negatively regulate inflammatory signaling.
Morosky SA et al. J Biol Chem 2011 Aug;286(32)28574-28583
Morosky SA, Zhu J, Mukherjee A, Sarkar SN, Coyne CB.
J Biol Chem 2011 Aug;286(32)28574-28583
Abstract: Cytoplasmic caspase recruiting domain (CARD)-containing molecules often function in the induction of potent antimicrobial responses in order to protect mammalian cells from invading pathogens. Retinoic acid-induced gene-I (RIG-I) and nucleotide binding oligomerization domain 2 (NOD2) serve as key factors in the detection of viral and bacterial pathogens, and in the subsequent initiation of innate immune signals to combat infection. RIG-I and NOD2 share striking similarities in their cellular localization, both localize to membrane ruffles in non-polarized epithelial cells and both exhibit a close association with the junctional complex of polarized epithelia. Here we show that RIG-I and NOD2 not only colocalize to cellular ruffles and cell-cell junctions, but that they also form a direct interaction that is mediated by the CARDs of RIG-I and multiple regions of NOD2. Moreover, we show that RIG-I negatively regulates ligand-induced nuclear factor-κB (NF-κB) signaling mediated by NOD2, and that NOD2 negatively regulates type I interferon induction by RIG-I. We also show that the three main Crohn disease-associated mutants of NOD2 (1007fs, R702W, G908R) form an interaction with RIG-I and negatively regulate its signaling to a greater extent than wild-type NOD2. Our results show that in addition to their role in innate immune recognition, RIG-I and NOD2 form a direct interaction at actin-enriched sites within cells and suggest that this interaction may impact RIG-I- and NOD2-dependent innate immune signaling.